News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–15
Matches
15
Sources here
6
Companies here
1
Search results Stored financial headlines

Active search

15 matching headlines

Ticker or company: T1CH34Main company stories
Clear
Latest

finance.yahoo.com Earnings

Bio-Techne Corrects Dividend Announcement

MINNEAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record date as August 17, 2026. The correct shareholder of record date is August 24, 2026. All other information contained in the dividend announcement remains unchanged. Bio-Techne Corporation announced that …

Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales

Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts' …

T1CH34 main company
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 27.5% T1CH34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bio-Techne Posts Q4 Net Profit As Expenses Drop, Net Sales Improve

(RTTNews) - Bio-Techne Corporation (TECH), a provider of life science reagents, instruments, and services, on Wednesday reported net profit for the fourth quarter of fiscal 2026. For the three-month period to June 30, the company posted net profit of $54.622 million, or $0.35 per …

T1CH34 main company
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 27.5% T1CH34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2026. Fourth Quarter FY2026 Highlights Fourth quarter organic revenue increased by 3% (1% reported) to $321.2 million. Full year organic and reported …

T1CH34 main company
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 27.5% T1CH34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bio-Techne Declares Dividend

MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly dividend will be payable August 28, 2026, to all …

T1CH34 main company
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 27.5% T1CH34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Bio-Techne (TECH) Above Fair Value After A 44% Return?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Bio-Techne stock has delivered a strong 44.2% return over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market …

T1CH34 main company
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 27.5% T1CH34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

JAZZ vs. TECH: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Jazz Pharmaceuticals (JAZZ) and Techne (TECH). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their …

T1CH34 main company
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 27.5% T1CH34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Investors’ Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 …

T1CH34 main company
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 27.5% T1CH34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

2 S&P 500 Stocks to Keep an Eye On and 1 We Turn Down

2 S&P 500 Stocks to Keep an Eye On and 1 We Turn Down While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, …

T1CH34 main company
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 27.5% T1CH34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock?

Bio-Techne Corporation TECH is expected to release fourth-quarter fiscal 2026 results on Aug. 5. The life science and diagnostic product maker posted adjusted earnings per share (EPS) of 53 cents in the last reported quarter, missing the Zacks Consensus Estimate by 3.64%. The company's …

T1CH34 main company
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 27.5% T1CH34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context